Cargando…

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)

Detalles Bibliográficos
Autores principales: Park, Anthony K, Priceman, Saul, Gerdts, Ethan, Chang, Wen-Chung, Wright, Sarah, Forman, Stephen J, Brown, Christine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645161/
http://dx.doi.org/10.1186/2051-1426-3-S2-P119
_version_ 1782400775980318720
author Park, Anthony K
Priceman, Saul
Gerdts, Ethan
Chang, Wen-Chung
Wright, Sarah
Forman, Stephen J
Brown, Christine E
author_facet Park, Anthony K
Priceman, Saul
Gerdts, Ethan
Chang, Wen-Chung
Wright, Sarah
Forman, Stephen J
Brown, Christine E
author_sort Park, Anthony K
collection PubMed
description
format Online
Article
Text
id pubmed-4645161
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46451612015-11-20 Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII) Park, Anthony K Priceman, Saul Gerdts, Ethan Chang, Wen-Chung Wright, Sarah Forman, Stephen J Brown, Christine E J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645161/ http://dx.doi.org/10.1186/2051-1426-3-S2-P119 Text en Copyright © 2015 Park et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Park, Anthony K
Priceman, Saul
Gerdts, Ethan
Chang, Wen-Chung
Wright, Sarah
Forman, Stephen J
Brown, Christine E
Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title_full Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title_fullStr Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title_full_unstemmed Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title_short Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
title_sort development of chimeric antigen receptor (car) t-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant iii (egfrviii)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645161/
http://dx.doi.org/10.1186/2051-1426-3-S2-P119
work_keys_str_mv AT parkanthonyk developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT pricemansaul developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT gerdtsethan developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT changwenchung developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT wrightsarah developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT formanstephenj developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii
AT brownchristinee developmentofchimericantigenreceptorcartcellimmunotherapyforglioblastomatargetingepidermalgrowthfactorreceptorvariantiiiegfrviii